Search Login Register

Erythromycin (Erycette) Summary

Description: A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.

Also Known As: Erycette; Erymax; Erythromycin A; Erythromycin C; Erythromycin Lactate; Erythromycin Phosphate; Ilotycin; T-Stat; C, Erythromycin; Lactate, Erythromycin; Phosphate, Erythromycin; T Stat; TStat

Networked: 3197 relevant articles (379 outcomes, 398 trials/studies) for this Drug

Key Diseases for which Erythromycin is Relevant

  1. Infection : 70 outcomes 61 studies in 620 results
  2. Pneumonia (Pneumonitis) : 37 outcomes 22 studies in 209 results
  3. Acne Vulgaris : 26 outcomes 29 studies in 152 results
  4. Inflammation : 12 outcomes 12 studies in 51 results
  5. Respiratory Tract Infections (Respiratory Tract Infection) : 10 outcomes 15 studies in 108 results
Show All >>

Drugs Related to Erythromycin

  1. Clarithromycin (Biaxin)
  2. Azithromycin (Zithromax)
  3. Tetracycline (Achromycin)
  4. Anti-Bacterial Agents (Antibiotics)
  5. Penicillins (Penicillin)
  6. Rifampin (Rifampicin)
  7. Amoxicillin (Wymox)
  8. Clindamycin (Cleocin)
  9. Doxycycline (Vibramycin)
  10. Macrolides
Show All >>

Therapies Related to Erythromycin

  1. Aftercare (After-Treatment)
  2. Enteral Nutrition (Feeding, Tube)
  3. Drug Therapy (Chemotherapy)
  4. Injections
  5. Chemoprevention
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.